CORRELATIONS WITH BONE MINEAL DENSITY IN MALE PATIENTS WITH CHRONIC ALCOHOLIC LIVER DISEASE
- OSTEOPOROZA ÃŽN SPONDILITA ANCHILOZANTÄ‚: II ETIOPATOGENEZÄ‚. // Romanian Journal of Rheumatology;2010, Vol. 19 Issue 3, p156
No abstract available.
- Hepatic Osteodystrophy Is Common in Patients with Noncholestatic Liver Disease. Choudhary, N.; Tomar, M.; Chawla, Y.; Bhadada, S.; Khandelwal, N.; Dhiman, R.; Duseja, A.; Bhansali, A. // Digestive Diseases & Sciences;Nov2011, Vol. 56 Issue 11, p3323
Background: Patients with cirrhosis are more prone to develop metabolic bone disease. Scanty literature data are available on osteodystrophy in patients from India with noncholestatic liver diseases. Methods: Patients diagnosed with cirrhosis were prospectively evaluated for bone mineral density...
- Metabolic Bone Disease. Frame, Boy; Parfitt, A. M. // Annals of Internal Medicine;Oct72, Vol. 77 Issue 4, p655
Focuses on methods and techniques for diagnosing several metabolic bone diseases, as discussed during the 1972 Clinical Aspects of Metabolic Bone Disease symposium in Detroit, Michigan. Information on the photon absorption method; Details on the use of calcitonin, mithramycin and diphosphonates...
- Osteoporosis en pacientes con hepatopatÃas crÃ³nicas: una complicaciÃ³n tardÃa poco conocida. García Botina, Hernán David; Córdoba Ramírez, Nathalia; Marín, Juan Ignacio; Restrepo Gutiérrez, Juan Carlos // Revista Colombiana de GastroenterologÃa;Oct2011, Vol. 26 Issue 4, p292
Hepatic osteodystrophy is a frequent late complication in chronic liver diseases in which patients usually present bone mineral density reduction, osteopenia, osteoporosis and fractures. Strategies to decrease incidence, avoid comorbidity and improve patient quality of life have yet to be...
- Chaparral herbal product causes liver damage. // NCAHF Newsletter (08903417);Mar/Apr95, Vol. 18 Issue 2, p3
Reports on the potential of chapparal herbal products to cause liver damage in humans. Preparation of the herbal products; Chapparal's effects on cancer.
- liver function, risk for impaired. // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1357
A definition of the term "liver function, risk for impaired," which refers to the risk for liver dysfunction, is presented.
- Orlistat-containing medicines under review. // WHO Drug Information;2011, Vol. 25 Issue 4, p365
No abstract available.
- Where are we now with paracetamol? Important questions remain unanswered about the most widely used drug in the UK. Dear, James W.; Antoine, Daniel J.; Park, B. Kevin // BMJ: British Medical Journal;7/18/2015, Vol. 351 Issue 8017, ph3705
The authors reflect on paracetamol, a drug introduced into the medical practice in Great Britain in 1956. Topics discussed include questions regarding the drug's efficiency and safety such as risk of liver injury, rise in alanine transaminase for those with osteoarthritis and potential to...
- RISK OF OSTEOPOROSIS IN CHILDREN WITH CHRONIC LIVER DISEASES. Ismail, Nagwa A.; El-Shabrawi, Mortada; Fatouh, Amany A.; Salama, Emad; Abd El Baky, Abeer M.; El Ghoroury, Eman A.; Thabet, Eman H. // International Journal of Academic Research;Sep2010, Vol. 2 Issue 5, p72
Background and Aim: Bone manifestations are well-known extrahepatic complications in patients with chronic liver diseases (CLD). In these patients, several factors contribute to the development of bone disease. Our aim was to determinate bone mineral density (BMD), bone mineral content (BMC),...